Skip to main content

Table 6 Cost-effectiveness table per number of retrieved oocytes (average results per treated patient)

From: Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF

 

Cost

QALYs

Incremental Cost

Incremental QALYs

ICER per QALYs

≥ 5 oocytes

 HP-hMG

€ 1256

0.71

   

 r-FSH + r-LH

€ 1742

0.76

€ 487

0.04

€ 11,365

5 ≤ oocytes ≤ 9

 HP-hMG

€ 1254

0.70

   

 r-FSH + r-LH

€ 1726

0.73

€ 472

0.03

€ 16,309

10 ≤ oocytes ≤ 15

 HP-hMG

€ 1254

0.72

   

 r-FSH + r-LH

€ 1751

0.80

€ 497

0.08

€ 6569

≥ 16 oocytes

 HP-hMG

€ 1272

0.78

   

 r-FSH + r-LH

€ 1824

0.82

€ 551

0.04

€ 12,274